Target ALS Foundation, focused on finding new treatments for amyotrophic lateral sclerosis (ALS), has selected RUCDR Infinite Biologics as…
Margarida Azevedo, MSc
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Azevedo, MSc
A group of women in their 60s decided to go full Monty to raise awareness for amyotrophic lateral sclerosis (ALS).
Who Was Lou Gehrig?
Amyotrophic lateral sclerosis (ALS) is commonly referred to as Lou Gehrig’s disease. But who was Lou Gehrig and…
Researchers at the Karolinska Institute in Sweden and the University of Barcelona in Spain studied the contribution of cellular redox…
Researchers at the University of California-Riverside have shown, for the first time, that infection from the common parasite Toxoplasma gondii disrupts…
Rapporteurs appointed by the European Medicines Agency (EMA) have recommended that AB Science SA’s combined treatment ‘masitinib with riluzole’ in the treatment…
A multi-disciplinary team of researchers analyzed the genotype data of thousands of ALS patients, with the objective of identifying gene…
Amyotrophic lateral sclerosis (ALS) severely burdens skeletal muscles, while eye muscles remain far less affected. Vahid M. Harandi, a doctoral…
Blood serum levels of progranulin, a key protein to both neuronal survival and neurodegenerative diseases, are not adequate measures of progranulin levels in the…
More than $200,000 was raised for Compassionate Care ALS (CCALS) during gala dinner May 21 at the Fairmont Copley hotel, in…